Your browser doesn't support javascript.
loading
Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study.
Pradhan, Richeek; Yu, Oriana H Y; Platt, Robert W; Azoulay, Laurent.
Affiliation
  • Pradhan R; Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Québec, Canada.
  • Yu OHY; Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Montreal, Québec, Canada.
  • Platt RW; Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Montreal, Québec, Canada.
  • Azoulay L; Division of Endocrinology, Jewish General Hospital, Montreal, Québec, Canada.
BMJ Open Diabetes Res Care ; 11(6)2023 11.
Article in En | MEDLINE | ID: mdl-37949470
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Melanoma Limits: Humans Language: En Journal: BMJ Open Diabetes Res Care Year: 2023 Document type: Article Affiliation country: Canadá
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Melanoma Limits: Humans Language: En Journal: BMJ Open Diabetes Res Care Year: 2023 Document type: Article Affiliation country: Canadá